Seth Lerner, M.D., FACS
Professor of Urology
Baylor College of Medicine
Seth P. Lerner,  Professor of Urology and Beth and Dave Swalm Chair in Urologic Oncology, earned his M.D. degree at Baylor College of Medicine. He completed two years of General Surgery training at the Virginia Mason Clinic in Seattle before returning to Baylor to complete his residency training in urology.  After a one-year AFUD/National Kidney Foundation fellowship and one-year American Cancer Society fellowship in urologic oncology at the University of Southern California, he returned to Houston in 1992 to join the faculty of the Scott Department of Urology. Last year he was appointed to the Beth and Dave Swalm Chair in Urologic Oncology.

Listed “Best Doctors in America” and “America’s Top Doctors,” he has special clinical interests in bladder, testis, prostate, and kidney cancer and in reconstructive surgery, especially continent urinary diversion.  His research interests are focused on bladder cancer chemoprevention, molecular markers, and gene therapy, and on clinical trials of novel treatment strategies for local and advanced bladder cancer.He is principal or co-investigator of several NIH-funded clinical trials for treatment of bladder cancer, and is principal investigator of SWOG Urologic Cancer Outreach program. He is co-principal investigator for a long-term study of bladder cancer risk in an “at risk,” occupationally exposed population.  He also acts as director of SDU’s continuing education program, organizing the department’s popular 3-day course in Santa Fe, New Mexico, every year.  He has published widely and serves as a member of the Board of Consultants for the Journal of Urology and as a Section Editor for Urologic Oncology as well as a reviewer for JCNI and Cancer.
Click here for more information.